# Audie Murphy pilot sources

Status: draft. Reopened for clinical and safe-messaging review after the focused visits, preventive and sick visits, and consultation were added.

## Government sources

1. Arlington National Cemetery. “Audie Murphy.” Supports military chronology, wounds, death, postwar symptoms, retrospective PTSD description, and the reported firearm-under-pillow statement. https://arlingtoncemetery.mil/Explore/Notable-Graves/Medal-of-Honor-Recipients/World-War-II-MoH-recipients/Audie-Murphy
2. U.S. Department of Defense. “Medal of Honor Monday: Army Maj. Audie Murphy,” January 27, 2025. Corroborates birth date, service history, insomnia, depression, and retrospective PTSD description. https://www.defense.gov/News/Feature-Stories/Story/Article/4035082/medal-of-honor-monday-army-maj-audie-murphy/
3. U.S. Department of Veterans Affairs, Veterans Legacy Memorial. “Audie L Murphy.” Corroborates birth date, death date, rank, service, and decorations. https://www.vlm.cem.va.gov/AUDIELMURPHY/2E228
4. National Archives. “A Heart of Purple.” Context for decorations and archival holdings. https://www.archives.gov/publications/prologue/2012/winter/heart-of-purple

## Clinical guideline

5. VA/DoD. “Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder,” 2023. https://www.healthquality.va.gov/HEALTHQUALITY/guidelines/MH/ptsd/

## Terminology sources

6. CDC/NCHS. “ICD-10-CM Files,” FY2026. https://www.cdc.gov/nchs/icd/icd-10-cm/files.html
7. Regenstrief Institute. “Post traumatic stress disorder checklist - civilian version DSM-5 [PCL-5],” LOINC 101697-1; total score 101698-9. https://loinc.org/101697-1/panel
8. Regenstrief Institute. “Patient Health Questionnaire 9 item (PHQ-9) total score [Reported],” LOINC 44261-6. https://loinc.org/44261-6
9. Regenstrief Institute. “Vital signs, weight, height, head circumference, oxygen saturation and BMI panel,” LOINC 85353-1. https://loinc.org/85353-1
10. VA/DoD. “Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide,” 2024. https://healthquality.va.gov/HEALTHQUALITY/guidelines/mh/srb/index.asp
11. VA/DoD. “Clinical Practice Guideline for Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea,” 2025. https://www.healthquality.va.gov/guidelines/CD/insomnia/index.asp

## Clinical guidance added for the batch standard

12. CMID: Clinical Monitoring Intelligence Database (Aether Forge, 2026), depression monograph. PHQ-9 at baseline, at least monthly during active treatment, and periodically in recovery; suicide-risk reassessment at every visit during active treatment; a bipolar screen when a depressive episode is diagnosed. Used for the PHQ-9 and suicide-risk rows of the focused visits. https://patrickrutledge.github.io/topthirty/
13. Harris AM, Hicks LA, Qaseem A. "Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and Prevention." *Ann Intern Med* 2016;164(6):425-434. No antibiotics, strep testing, or chest radiograph for the common cold without signs of pneumonia. Used for the sick visit. https://pubmed.ncbi.nlm.nih.gov/26785402/
14. U.S. Preventive Services Task Force recommendations used at the adult preventive visit for a 40-year-old man: A and B Recommendations, https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations; Depression and Suicide Risk in Adults: Screening (2023), https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults; Unhealthy Alcohol Use in Adolescents and Adults (2018), https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions; Unhealthy Drug Use: Screening (2020), https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/drug-use-illicit-screening; Hypertension in Adults: Screening (2021), https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hypertension-in-adults-screening; Prediabetes and Type 2 Diabetes: Screening (2021), https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-for-prediabetes-and-type-2-diabetes; Statin Use for the Primary Prevention of Cardiovascular Disease in Adults (2022), https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/statin-use-in-adults-preventive-medication; HIV Infection: Screening (2019), https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening; Hepatitis C Virus Infection in Adolescents and Adults: Screening (2020), https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening.
15. Centers for Disease Control and Prevention. "Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations, United States, 2023." *MMWR Recomm Rep* 2023;72(1). One-time triple-panel screening for adults. https://pubmed.ncbi.nlm.nih.gov/36893044/
16. Medicare Preventive Services reference (Aether Forge, 2026). The preventive visit template (history, review of systems, examination, assessment and plan, and screening cascade) that the visit note follows. https://patrickrutledge.github.io/preventative_services/

Each URL in this section was checked with curl on November 3, 2026 and resolved.

## Evidence gaps before clinical generation

- Obtain and review Murphy’s memoir, *To Hell and Back*, as a primary text.
- Locate reliable source support for prescription sedative dependence before retaining it as a historical claim.
- Determine whether a publicly available 1947 post-service examination can be cited directly.
- Verify the extent and dates of depression, headaches, nightmares, and insomnia without copying later biographies into one another.
- Review the roster’s alcohol-use assertion; current government sources reviewed here do not establish it.
- Have a second reviewer adjudicate the 1924 versus 1925 birth-year discrepancy.

## Current evidence treatment

- Symptoms directly described by government biographies are `D`.
- The PTSD label is `R` because it is a retrospective modern diagnosis.
- Any active modern diagnosis, assessment score, vital sign, medication, dose, laboratory result, or treatment response will be `S`.

## Editorial resolutions

- **Review reopened.** The owner asked for this pilot to be brought up to the batch standard, which reopens its review. The release status is now draft, and the clinical and safe-messaging reviews are in progress; the approval of November 2, 2026 covered only the earlier content. The provenance review, the schema validation entry, and the claims' release status are unchanged.
- **Focused visits.** The six-week and twelve-week follow-ups (ENC-002 and ENC-003) are documented as focused visits. PTSD and chronic insomnia are not CMID conditions, so the protocol tables follow the VA/DoD guidelines the case already cites: the PCL-5 at the care-plan intervals, trauma-focused psychotherapy, alcohol and substance-use checks, no benzodiazepines, the sleep routine, a sleep apnea symptom screen, and cognitive behavioral therapy for insomnia if insomnia persists. The CMID depression monograph is used for the PHQ-9 cadence, the every-visit suicide-risk reassessment, and the bipolar screen rule. Each visit reviews the intake safety assessment and safety plan, describing lethal-means steps only generically, with no method or weapon detail and no restatement of the historical firearm claim. Synthetic findings introduced: nightmares falling from most nights to two or three a week and then to about once a week; sleep onset of about 30 and then about 20 minutes; five therapy sessions by six weeks (nine in total, as recorded); the mental status findings; and negative since-last-visit suicide screens, reported as negative screens without any PHQ-9 item-level response, in keeping with the terminology ledger's deferral of item-level responses. Protocol deviations recorded instead of invented results: (1) the intake PHQ-9 of 11 was rechecked at six weeks instead of about four; the six-week score of 7 shows no harm, and the consultant found no separate depressive disorder, so the PHQ-9 then follows the PCL-5 schedule; (2) no sleep apnea symptom screen was documented at intake; it was done at six weeks and was negative.
- **Sick and preventive visits.** Two visits were added after the chronic-care schedule: an unscheduled sick visit (ENC-004) on October 6, 2026 (true frame October 6, 1964) for a common cold, and an adult preventive visit (ENC-005) on October 27, 2026 (true frame October 27, 1964). Both are synthetic, keep the index age of 40, and fall well before his death in 1971, so no documented event is contradicted. The cold does not echo a documented illness. It was chosen because cough and nasal blockage disrupt his recovered sleep, and the over-the-counter remedies a patient would reach for (sedating antihistamine "nighttime" products, oral decongestants, and alcohol-containing syrups) conflict with his insomnia plan, his hyperarousal, and his blood pressure. The visit adds no sedative, in keeping with the decision not to retain the unverified sedative-dependence assertion, and no alcohol use, in keeping with the decision not to adopt the roster's alcohol assertion (the AUDIT-C at the preventive visit is 0). The preventive visit follows USPSTF adult preventive services for a 40-year-old man, with a same-day PHQ-9 of 3 and this season's influenza vaccine. Lipid, HbA1c, HIV, hepatitis C, and hepatitis B tests are ordered, and their results are not recorded. Office blood pressures of 124 to 132 over 78 to 84 mmHg are noted as elevated readings and followed with home readings, without a hypertension diagnosis. The visit records no scar or other finding from the historical war wounds and no hearing finding. Its advance care planning names no health care agent and no real person.
- **Consultation.** The behavioral health referral and the consultation by Marcus Lee, PsyD, a fictional consultant, on the day of the six-week visit are synthetic. Dr. Lee is written as the clinician who delivers the Cognitive Processing Therapy, so his report at six weeks follows his evaluation at the start of care and five sessions. The examination is a mental status examination matching Dr. Marquez's same-day findings, and the assessment includes a suicide-risk formulation (low acute risk; chronic risk raised by combat exposure, PTSD, and insomnia). The recommendations are what the record then shows: completing the course (nine sessions), no PTSD or sleep medication, no benzodiazepines or sedating sleep aids, cognitive behavioral therapy for insomnia only if insomnia persists (not needed), the PHQ-9 with the PCL-5 at twelve weeks, and the safety plan reviewed at every visit. Judgment calls: (1) the consultant finds no separate depressive disorder despite the intake PHQ-9 of 11, which the six-week deviation row relies on; (2) the trauma is described only as combat service, with no detail of any historical action; (3) no CAPS-5 or other structured-interview score is invented.
